Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil

Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.